The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
Approval strengthens the company’s growing international anti-infective portfolio
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The approval enables the company to directly sell health insurance plans to individuals and families while integrating its managed healthcare delivery model into retail offerings
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
More than 3,500 participants will join the nationwide AI-focused hackathon hosted as Indian Institute of Science
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
